1.Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015;372(13):1213–1222.2.Fearon WF, Nishi T, De Bruyne B, et al. Fractional flow reserve–guided PCI as compared with coronary bypass surgery. N Engl J Med. 2022;386(16):1391–1400.3.Gaudino M, et al. Arterial grafting versus venous grafting in coronary bypass surgery. N Engl J Med. 2018;378(22):2069-2077.4.Généreux P, Palmerini T, Caixeta A, et al. SYNTAX score II: a novel tool for guiding the revascularization strategy. J Am Coll Cardiol. 2013;62(14):1214–1224.5.Harskamp RE, et al. Comparison of outcomes of hybrid coronary revascularization versus percutaneous coronary intervention. Am J Cardiol. 2014;113(10):1676-1683.6.Head SJ, et al. Coronary artery bypass grafting: Part 2—Optimizing outcomes and future prospects. Eur Heart J. 2013;34(37):2873-2886.7.Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis. Lancet. 2018;391(10124):939–948.8.Holm NR, Mäkikallio T, Lindsay MM, et al. PCI guided by FFR or angiography in patients with multivessel disease. N Engl J Med. 2022;386(16):1409–1419.9.Holzhey DM, et al. Minimally invasive hybrid coronary artery revascularization. J Thorac Cardiovasc Surg. 2013;145(1):S85-S90.10.Maron DJ, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395-1407.11.Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395–1407.12.Mehta SR, Wood DA, Storey RF, et al. Complete revascularization with multivessel PCI for myocardial infarction.N Engl J Med. 2019;381:1411–1421.13.Neumann FJ, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165.14.Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.15.Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors. J Am Coll Cardiol. 2020;76(25):2982-3021.16.Serruys PW, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.17.Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972.18.Shroyer ALW, et al. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361(19):1827-1837.19.Stone GW, et al. FAME 3: Fractional flow reserve-guided PCI versus CABG in multivessel coronary artery disease. N Engl J Med. 2022;386:1189-1199.20.Taggart DP, Altman DG, Gray AM, et al. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016;375(26):2540–2549.21.Taggart DP, et al. ROMA trial rationale and design. Eur J Cardiothorac Surg. 2020;58(4):734-742